Arbutus Biopharma (ABUS) Change in Cash (2013 - 2026)

Arbutus Biopharma has disclosed Change in Cash across 14 years of filings, most recently posting $5.7 million for Q1 2026.

• Change in Cash for Q1 2026 came in at $5.7 million, up 663.81% year-over-year; the trailing twelve-month figure through Mar 2026 was -$13.4 million (down 121.91% YoY), and the FY2025 annual result was -$18.3 million, down 282.4% from the prior year.
• Change in Cash came in at $5.7 million for Q1 2026 at Arbutus Biopharma, up from -$4.4 million in the prior quarter.
• In the past five years, Change in Cash ranged from a high of $19.7 million in Q2 2024 to a low of -$34.0 million in Q2 2022.
• The 5-year median for Change in Cash is $336000.0 (2025), against an average of -$5.0 million.
• Across the five-year window, Change in Cash sank 220.11% in 2024 and soared 663.81% in 2026, its largest moves.
• Arbutus Biopharma's Change in Cash stood at $6.8 million in 2022, then increased by 29.27% to $8.8 million in 2023, then sank by 48.78% to $4.5 million in 2024, then tumbled by 198.13% to -$4.4 million in 2025, then jumped by 229.5% to $5.7 million in 2026.
• The last three Change in Cash figures came in at $5.7 million (Q1 2026), -$4.4 million (Q4 2025), and -$15.0 million (Q3 2025), per Business Quant data.